0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cidofovir"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,490USDGBP
Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$5,850USDGBP
Smallpox - Pipeline Insight, 2025 - Product Thumbnail Image

Smallpox - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
  • 8 Results (Page 1 of 1)
Loading Indicator

Cidofovir is an antiviral drug used to treat infections caused by certain viruses, including cytomegalovirus (CMV) and adenovirus. It is used to treat CMV retinitis, a serious eye infection that can lead to blindness, and is also used to treat adenovirus infections in people with weakened immune systems. Cidofovir is administered intravenously and is usually given in combination with other antiviral medications. Common side effects include nausea, vomiting, and diarrhea. Cidofovir is a part of the larger market of infectious diseases drugs, which are used to treat a variety of bacterial, viral, and fungal infections. These drugs are used to treat a wide range of conditions, from common colds to more serious illnesses such as HIV/AIDS and tuberculosis. Infectious diseases drugs are an important part of the healthcare system, as they help to reduce the spread of disease and improve patient outcomes. Companies in the cidofovir market include Gilead Sciences, Merck, and Bristol-Myers Squibb. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more